Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04755335 · ClinicalTrials.gov registry record
Ultrasonic Perfusion Estimation in Calf Muscle
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 87
- Enrollment target
NCT04755335: Completed study, sponsored by Mayo Clinic.
NCT04755335 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04755335 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the potential of ultrasound perfusion imaging technique for assessing the progression of peripheral arterial disease (PAD) and monitoring its response to therapy by measuring changes in microvessel alterations and perfusion variations.
Primary Outcome
Perfusion density of the cuff muscle will be quantified by the new automatic ultrasound microvessel quantification technique and the resulting measurements will measure the outcome of this part of the study.
Interventions
- DIAGNOSTIC_TEST Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2020-02-28 |
| Est. Completion | 2023-05-29 |
What the finished NCT04755335 record still lists
NCT04755335 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound is the first listed.
NCT04755335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04755335 about?
NCT04755335 is a clinical study titled "Ultrasonic Perfusion Estimation in Calf Muscle". The purpose of this study is to evaluate the potential of ultrasound perfusion imaging technique for assessing the progression of peripheral arterial disease (PAD) and monitoring its response to therapy by measuring changes in microvessel alterations and perfusion variations.
What is the current status of trial NCT04755335?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2020-02-28. Estimated completion is 2023-05-29.
What interventions are being tested in trial NCT04755335?
The interventions under investigation include: Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04755335?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI